The 5 analysts offering 12-month price forecasts for Surface Oncology Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +506.06% increase from the last price of 1.98.
The current consensus among 6 polled investment analysts is to Buy stock in Surface Oncology Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.45
Reporting Date Aug 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.